An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC.

The preparation isolated a mechanistic question

Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed coronary flow and contractile responses, with a more pronounced response on first administration. The isolated preparation does not reproduce every regulatory process in a living person.

Pathway interventions supplied comparisons

The investigators tested 2-AG, an experimental cannabinoid agonist, a CB1 blocker and an inhibitor relevant to endocannabinoid production. The pattern supported modulation through endocannabinoid release and receptor activation. It did not directly quantify a clinical cannabis effect.

Different response levels should remain separate

Coronary flow, contractility and metabolic-demand interpretations are related but distinct. The proposed pathway helps explain results within the model. It cannot establish that stimulating the same system with a different compound, route or dose has a beneficial cardiovascular outcome in patients.

Interpreting the evidence

This study is relevant to cannabinoid-system physiology, not a marijuana treatment recommendation. It does not show that cannabis improves coronary flow, protects the heart or produces the same response as an endogenous signal. Model, intervention and measured endpoint must remain explicit.

Related reading: interpreting cannabis tolerance claims.

Research reference

Miklós Z; Wafa D; Nádasy GL; Tóth ZE; Besztercei B; Dörnyei G; Laska Z; Benyó Z; Ivanics T; Hunyady L; Szekeres M (2021). Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB1 Receptor Activation. Cells. doi:10.3390/cells10040724.

This analysis draws on the supplied abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC. The preparation isolated a mechanistic question Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed…

Spread the love

Read Article: An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A 1999 isolated guinea-pig intestinal-tissue experiment found bidirectional cross-tolerance between morphine and WIN 55,212-2. Yet antagonist-triggered contraction did not appear symmetrically, limiting a simple claim that the two dependence states were identical. The model measured tissue responses Myenteric-plexus longitudinal-muscle preparations were incubated with the compounds and tested through electrically evoked…

Spread the love

Read Article: An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

A 1998 mouse study used a CB1 antagonist to precipitate withdrawal after repeated THC. Its behavioral findings support an experimental dependence model, while remaining different from the natural course of human cannabis withdrawal. The trigger was an administered antagonist After repeated THC, antagonist challenge promptly increased paw tremors and head…

Spread the love

Read Article: A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us